Why Moderna and BioNTech Topped the Market Today

·2 min read
Why Moderna and BioNTech Topped the Market Today

Shares of coronavirus stocks Moderna (NASDAQ: MRNA) and BioNTech (NASDAQ: BNTX) rose on Thursday by 1.4% and 4.9%, respectively, in contrast to the stock market's dip on the day. This followed news that the two companies had their coronavirus vaccines fully approved by a national regulator. On Thursday morning, it switched on the green light for both Moderna's mRNA-1273 (brand-named SpikeVax) and Comirnaty from BioNTech and its development partner Pfizer (NYSE: PFE).

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting